PONS · Fabrication of Polysaccharides-Protein complex Nano-Hybrid Scaffold as regenerative biomaterial for bone tissue engineering

Fabrication of Polysaccharides-Protein complex Nano-Hybrid Scaffold as regenerative biomaterial for bone tissue engineering

The Pol-PrO complex reinforced LDH-BCM Nanohybrid Scaffold (PONS) was developed as regenerative biomaterial in bone tissue engineering. The 3D nano hybrid scaffold was developed by optimizing the concentration and the ratio of blending of the Pol-Pro complex. The nano hybrid Pol-Pro complex scaffold was fabricated by incorporating layered double hydroxide coated with rutin as biological carrier molecule to enhance the bone regeneration using freeze drying technology. The nano hybrid scaffold were physio-chemically and biologically evaluated for application in bone tissue engineering. Thus this proposal aim was attained by fabricated an organic-inorganic complex nanohybrid scaffold as a bone implant for applications in tissue. - The project has achieved most of its objectives and milestones for the period, with relatively minor deviations. O1.Synthesis and characterization of BMP2 conjugated LDH nanohybrid as the functional biological career molecule O2.Fabrication and evaluation of the LDH nanohybrid reinforced Polysaccharide-Protein (Pol-Pro) complex scaffold O3.Evaluation of the fabricated LDH nanohybrid Pol-Pro complex hybrid scaffold using in vitro, in situ and in vivo studies using mice as the animal model Objective 1, 2 and 3 was complete successfully as given below. However, part of the objective 3 (WP4) was unable to complete due to the COVID 19 situation. WP1: Synthesis, Characterization and conjugation of LDH nano-hybrid with BCM : The two different combination of LDH was prepared using aqueous mixed salt solution (Zn-Fe) by co-precipitation method. The prepared Zn-Fe LDH was characterized and coated with biologically active carrier molecule (BCM) to enhance the osteoblast adhesion and regeneration of bone. For this we have selected Rutin as the BCM and coated over the prepared Zn-Fe LDH and then incorporated into the Pol-Pro hybrid complex scaffold n WP 2.1. WP2: Design and development of nanohybrid reinforced Pol-Pro complex scaffolds WP2.1. Fabrication of LDH nano-hybrid reinforced Pol-Pro complex scaffold : The 3D hierarchical hybrid scaffold was fabricated with different weight percentage of Polysaccharide (Bacterial Cellulose) and Protein (Collagen) and were blended uniformly and poured into pre-designed moulds. The Pol-Pro complex mixture were frozen step by step at different temperature from -4°C, -20°C, -40°C and -80°C at constant time intervals followed by freeze drying for 24 h to obtain three-dimensional (3D) Pol-Pro complex scaffolds. The material with best porosity was chosen to reinforce LDH into the Pol-Pro complex scaffold and similarly, the LDH reinforced Pol-Pro complex scaffold was fabricated. All fabricated scaffold were sterilized and stored at 4°C until further use. WP2.2. Characterization of the fabricated LDH reinforce Pol-Pro complex scaffold The chemical and conformational changes of the fabricated scaffold were investigated using Fourier transform infrared (FTIR) measurements, to determine the functional groups. The surface morphology of the scaffolds will be visualized using SEM, and µCT analysis. The scaffolds were also evaluated for the bioactivity or mineralization assay in stimulated body fluid (SBF). The in vitro biodegradation, porosity and specific surface area of the scaffold were evaluated to ensure the oxygen permeability, metabolic exchange, cell seeding efficiency. Compression test. WP3: Evaluation of in situ and in vitro efficacy of LDH nano-hybrid reinforced Pol-Pro complex scaffolds: The in vitro evaluation of the fabricated nano-hybrid scaffold was done with bone cell line and we have got good biocompatibility of the scaffold. Along with biocompatibility, the live dead staining of the cells were done. WP4: Evaluation of the in vivo efficacy of LDH reinforced Pol-Pro complex hybrid 3D scaffolds using mice as the animal model: As a proof of the biocompatibility, further, in vivo studies on the developed scaffold was proposed to do. But due do the COVID 19 situation I am not unable to procced with that evaluation.

Data: CORDIS, © European Union